胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版)

2019-09-30 中国抗癌协会胃癌专业委员会 中国实用外科杂志.2019,39(9):881-889.

为了普及和规范我国胃癌根治术后标本中淋巴结规范送检的理念及操作细节,降低胃癌病人术后分期迁移率,并进一步客观反映我国胃癌的治疗效果,中国抗癌协会胃癌专业委员会、中华医学会肿瘤学分会胃肠学组、中国医师协会外科医师分会肿瘤外科医师委员会组织国内相关领域部分专家制定本共识。

中文标题:

胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版)

发布日期:

2019-09-30

简要介绍:

为了普及和规范我国胃癌根治术后标本中淋巴结规范送检的理念及操作细节,降低胃癌病人术后分期迁移率,并进一步客观反映我国胃癌的治疗效果,中国抗癌协会胃癌专业委员会、中华医学会肿瘤学分会胃肠学组、中国医师协会外科医师分会肿瘤外科医师委员会组织国内相关领域部分专家制定本共识。

 

拓展指南:胃癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版))] GetToolGuiderByIdResponse(projectId=1, id=cd2511c00180581d, title=胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版), enTitle=, guiderFrom=中国实用外科杂志.2019,39(9):881-889., authorId=null, author=, summary=为了普及和规范我国胃癌根治术后标本中淋巴结规范送检的理念及操作细节,降低胃癌病人术后分期迁移率,并进一步客观反映我国胃癌的治疗效果,中国抗癌协会胃癌专业委员会、中华医学会肿瘤学分会胃肠学组、中国医师协会外科医师分会肿瘤外科医师委员会组织国内相关领域部分专家制定本共识。 , cover=, journalId=null, articlesId=null, associationId=871, associationName=中国抗癌协会胃癌专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Sep 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>为了普及和规范我国胃癌根治术后标本中淋巴结规范送检的理念及操作细节,降低胃癌病人术后分期迁移率,并进一步客观反映我国胃癌的治疗效果,中国抗癌协会胃癌专业委员会、中华医学会肿瘤学分会胃肠学组、中国医师协会外科医师分会肿瘤外科医师委员会组织国内相关领域部分专家制定本共识。 </P> <P> </P>拓展指南:<strong>与<font color=red>胃癌</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=015011c001e767c8" title="中国幽门螺杆菌根除与胃癌防控的专家共识意见(2019年,上海)" target=_blank>中国幽门螺杆菌根除与胃癌防控的专家共识意见(2019年,上海)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ea4561c001e69a7f" title="2019 NCCN临床实践指南:胃癌(2019.V2)" target=_blank>2019 NCCN临床实践指南:胃癌(2019.V2)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b43f31c001ea1669" title="胃癌肝转移诊断与综合治疗中国专家共识(2019版)" target=_blank>胃癌肝转移诊断与综合治疗中国专家共识(2019版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=257f91c001e28949" title="2018 韩国实践指南:胃癌" target=_blank>2018 韩国实践指南:胃癌</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1571c1c001e2210c" title="2018 CSCO临床指南:胃癌的诊断和治疗(英文版)" target=_blank>2018 CSCO临床指南:胃癌的诊断和治疗(英文版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%83%83%E7%99%8C" target=_blank>有关胃癌更多指南</a></ul>, tagList=[TagDto(tagId=4531, tagName=胃癌根治术), TagDto(tagId=95821, tagName=标本规范), TagDto(tagId=95822, tagName=淋巴结送检)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4643, appHits=307, showAppHits=17, pcHits=2885, showPcHits=2389, likes=75, shares=22, comments=6, approvalStatus=1, publishedTime=Sat Oct 19 21:50:14 CST 2019, publishedTimeString=2019-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 19 21:50:14 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 04:02:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版))])
胃癌根治术标本规范淋巴结送检及操作中国专家共识(2019版)
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=958517, encodeId=89e995851edb, content=挺好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76465437807, createdName=ms2000000234438827, createdTime=Mon Apr 19 22:02:21 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925588, encodeId=bcbd925588cb, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/f170b7f2eb014d5d88660a74670c7d49/95bdcd8f1c754b198534303baddb0d7d.jpg, createdBy=4a6e5461309, createdName=合欢花, createdTime=Fri Feb 19 22:32:14 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905741, encodeId=19e8905e4170, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14605117228, createdName=chelsea., createdTime=Mon Dec 07 16:53:20 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904332, encodeId=2be29043323f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03991619212, createdName=zhumed360302, createdTime=Wed Dec 02 16:04:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897964, encodeId=426489e96459, content=赞一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/b185fc951281480888ff7a63814edb68/e261274e716849afafe1988af58890ae.jpg, createdBy=fe0d3678110, createdName=1346e390m63暂无昵称, createdTime=Mon Nov 09 14:59:37 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2021-04-19 ms2000000234438827

    挺好,学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=958517, encodeId=89e995851edb, content=挺好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76465437807, createdName=ms2000000234438827, createdTime=Mon Apr 19 22:02:21 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925588, encodeId=bcbd925588cb, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/f170b7f2eb014d5d88660a74670c7d49/95bdcd8f1c754b198534303baddb0d7d.jpg, createdBy=4a6e5461309, createdName=合欢花, createdTime=Fri Feb 19 22:32:14 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905741, encodeId=19e8905e4170, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14605117228, createdName=chelsea., createdTime=Mon Dec 07 16:53:20 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904332, encodeId=2be29043323f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03991619212, createdName=zhumed360302, createdTime=Wed Dec 02 16:04:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897964, encodeId=426489e96459, content=赞一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/b185fc951281480888ff7a63814edb68/e261274e716849afafe1988af58890ae.jpg, createdBy=fe0d3678110, createdName=1346e390m63暂无昵称, createdTime=Mon Nov 09 14:59:37 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2021-02-19 合欢花

    挺好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=958517, encodeId=89e995851edb, content=挺好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76465437807, createdName=ms2000000234438827, createdTime=Mon Apr 19 22:02:21 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925588, encodeId=bcbd925588cb, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/f170b7f2eb014d5d88660a74670c7d49/95bdcd8f1c754b198534303baddb0d7d.jpg, createdBy=4a6e5461309, createdName=合欢花, createdTime=Fri Feb 19 22:32:14 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905741, encodeId=19e8905e4170, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14605117228, createdName=chelsea., createdTime=Mon Dec 07 16:53:20 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904332, encodeId=2be29043323f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03991619212, createdName=zhumed360302, createdTime=Wed Dec 02 16:04:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897964, encodeId=426489e96459, content=赞一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/b185fc951281480888ff7a63814edb68/e261274e716849afafe1988af58890ae.jpg, createdBy=fe0d3678110, createdName=1346e390m63暂无昵称, createdTime=Mon Nov 09 14:59:37 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2020-12-07 chelsea.

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=958517, encodeId=89e995851edb, content=挺好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76465437807, createdName=ms2000000234438827, createdTime=Mon Apr 19 22:02:21 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925588, encodeId=bcbd925588cb, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/f170b7f2eb014d5d88660a74670c7d49/95bdcd8f1c754b198534303baddb0d7d.jpg, createdBy=4a6e5461309, createdName=合欢花, createdTime=Fri Feb 19 22:32:14 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905741, encodeId=19e8905e4170, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14605117228, createdName=chelsea., createdTime=Mon Dec 07 16:53:20 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904332, encodeId=2be29043323f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03991619212, createdName=zhumed360302, createdTime=Wed Dec 02 16:04:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897964, encodeId=426489e96459, content=赞一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/b185fc951281480888ff7a63814edb68/e261274e716849afafe1988af58890ae.jpg, createdBy=fe0d3678110, createdName=1346e390m63暂无昵称, createdTime=Mon Nov 09 14:59:37 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2020-12-02 zhumed360302

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=958517, encodeId=89e995851edb, content=挺好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76465437807, createdName=ms2000000234438827, createdTime=Mon Apr 19 22:02:21 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925588, encodeId=bcbd925588cb, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/f170b7f2eb014d5d88660a74670c7d49/95bdcd8f1c754b198534303baddb0d7d.jpg, createdBy=4a6e5461309, createdName=合欢花, createdTime=Fri Feb 19 22:32:14 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905741, encodeId=19e8905e4170, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14605117228, createdName=chelsea., createdTime=Mon Dec 07 16:53:20 CST 2020, time=2020-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904332, encodeId=2be29043323f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03991619212, createdName=zhumed360302, createdTime=Wed Dec 02 16:04:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897964, encodeId=426489e96459, content=赞一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/b185fc951281480888ff7a63814edb68/e261274e716849afafe1988af58890ae.jpg, createdBy=fe0d3678110, createdName=1346e390m63暂无昵称, createdTime=Mon Nov 09 14:59:37 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2020-11-09 1346e390m63暂无昵称

    赞一个

    0